Company Description
Anzu Special Acquisition Corp I (symbol: ANZU) is a special purpose acquisition company (SPAC) dedicated to merging with transformative technology enterprises, primarily in the industrial applications sector. Recently, Anzu concluded a significant merger with Envoy Medical Corporation, a pioneering hearing health company.
Anzu's core mission is to facilitate the advancement and commercialization of breakthrough technologies. The company is well-positioned to leverage its financial acumen and industry expertise to support Envoy Medical’s innovative efforts, particularly in the development of the Acclaim® Cochlear Implant. This fully implanted hearing device, which has received the FDA's Breakthrough Device Designation, represents a revolutionary shift in the hearing health industry by utilizing a sensor designed to capture sound through the natural anatomy of the ear, thus eliminating the need for external components.
The newly formed entity, New Envoy, will benefit from the guidance of a newly appointed board of directors comprised of seasoned professionals from leading medical and financial institutions such as Abbott, Medtronic, and PwC. This board aims to steer the company toward achieving regulatory milestones, expanding market reach, and enhancing shareholder value.
Financially, Anzu has demonstrated robust performance and secured significant shareholder support for its merger activities. Over 99% of votes at the recent special meeting approved the business combination with Envoy Medical. Following the merger's completion, New Envoy's Class A Common Stock and warrants are set to trade on NASDAQ under the symbols COCH and COCHW respectively, starting October 2, 2023.
Anzu's strategic focus on high-quality, high-potential businesses with transformative technologies positions it as a pivotal player in the industrial and medical technology markets. As part of its ongoing initiatives, Anzu and Envoy Medical plan to attend key industry conferences to discuss technological advancements and engage with investors, further solidifying their market position.
Stock Performance
Latest News
SEC Filings
No SEC filings available for Anzu Special Acquisition I.